What is the current Price Target for the Dyne Therapeutics Inc stock?

The average Dyne Therapeutics Inc target price is $37.74. This is 136.47% higher than the current stock price. The highest price target is 228.95%, the lowest is 64.54%. 15 Analysts have issued a price target Dyne Therapeutics Inc 2027 .

How high will the Dyne Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Dyne Therapeutics Inc stock will rise. The performance of stocks, including the Dyne Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Dyne Therapeutics Inc stock today?

The performance of Dyne Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Dyne Therapeutics Inc stock fall?

The decline in Dyne Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Dyne Therapeutics Inc Forecast, price target & analysts

$15.96

4.09%

Nasdaq, Oct 12, 04:26 pm EDT. Closed.

ISIN

US26817R1086

Symbol

DYN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Dyne Therapeutics Inc Target price 2026 - Analyst rating & recommendation

Dyne Therapeutics Inc Classifications & Recommendation

Buy

90%

Hold

10%

Dyne Therapeutics Inc Price Target

Target Price	$37.74
Price	$15.96
Potential	136.47% register free of charge
Number of Estimates	15

	15 Analysts have issued a price target Dyne Therapeutics Inc 2027 . The average Dyne Therapeutics Inc target price is $37.74. This is 136.47% register free of charge higher than the current stock price. The highest price target is $52.50 228.95% register free of charge , the lowest is $26.26 64.54% register free of charge .
	A rating was issued by 21 analysts: 19 Analysts recommend Dyne Therapeutics Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Dyne Therapeutics Inc stock has an average upside potential 2027 of 136.47% register free of charge . Most analysts recommend the Dyne Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-3.47	-3.66
	2.97%	5.48%
P/E		negative

18 Analysts have issued a Dyne Therapeutics Inc forecast for earnings per share. The average Dyne Therapeutics Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-3.47	2.97%
2026	$-3.66 5.48% unlock
2027	$-3.40 7.10% unlock
2028	$-2.58 24.12% unlock
2029	$-0.22 91.47% unlock
2030	$2.13 1,068.18% unlock
2031	$4.30 101.88% unlock
2032	$6.61 53.72% unlock
2033	$7.61 15.13% unlock

Current	-5.32	47.36%
2026	-4.54 14.60% unlock
2027	-4.90 7.93% unlock
2028	-6.46 31.84% unlock
2029	-74.89 1,059.29% unlock
2030	7.82 110.44% unlock
2031	3.87 50.51% unlock
2032	2.52 34.88% unlock
2033	2.19 13.10% unlock

Dyne Therapeutics Inc...

Current Dyne Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Chardan Capital	Locked ➜ Locked	Locked	Sep 30 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 30 2026
Piper Sandler	Locked ➜ Locked	Locked	Sep 29 2026
Baird	Locked ➜ Locked	Locked	Sep 09 2026
Morgan Stanley	Locked ➜ Locked	Locked	Sep 09 2026
RBC Capital	Locked ➜ Locked	Locked	Sep 09 2026
JP Morgan	Locked ➜ Locked	Locked	Sep 09 2026

Analyst Rating	Date
Locked Chardan Capital: Locked ➜ Locked	Sep 30 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 30 2026
Locked Piper Sandler: Locked ➜ Locked	Sep 29 2026
Locked Baird: Locked ➜ Locked	Sep 09 2026
Locked Morgan Stanley: Locked ➜ Locked	Sep 09 2026
Locked RBC Capital: Locked ➜ Locked	Sep 09 2026
Locked JP Morgan: Locked ➜ Locked	Sep 09 2026

Discover more stocks with a high price target

NIO ADR 81.81%

Alibaba Group Holding Ltd 75.50%

Rheinmetall 69.61%

Infineon 61.32%

Tencent Holdings Ltd. 59.54%

BYD 49.39%

TUI 48.22%

Deutsche Telekom 47.00%

Adyen 46.22%

Uber Technologies 42.66%

Siemens Energy 42.46%

NVIDIA 41.97%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now